Gufic Biosciences Ltd
NSE:GUFICBIO
Gufic Biosciences Ltd
NSE:GUFICBIO
Price:
272.2
INR
-2.28%
Market Closed
Market Cap:
₹27.3B
Relative Value
The Relative Value of one
GUFICBIO
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 272.2 INR,
Gufic Biosciences Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GUFICBIO Relative Value
HIDDEN
Multiples Across Competitors
GUFICBIO Competitors Multiples
Gufic Biosciences Ltd Competitors
Gufic Biosciences Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Gufic Biosciences Ltd
NSE:GUFICBIO
|
27.3B INR | 3.2 | 48.4 | 20.9 | 26.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
946.2B USD | 14.6 | 46 | 31 | 33.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.1B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.2B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.8B CHF | 5.6 | 22.5 | 13.9 | 17.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.4B GBP | 5.4 | 30.7 | 17 | 23.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.6 | 7.9 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
150.7B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
